Drugs / AZD6714
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00886366 | Apr → Sep 2009 | type 2 diabetes mellitus | AstraZeneca | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD6714 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00886366 ↗ |
| Route | Oral | “Oral single doses a-h suspension” NCT00886366 ↗ |